与神经发育障碍相关的synaptotagmin-1中的一个de novo误解突变使神经递质释放脱同步
Maaike A van Boven1, Marta Mestroni1, Petra J G Zwijnenburg2
1Department of Functional Genomics, Center for Neurogenomics and Cognitive Research (CNCR), Vrije Universiteit (VU) Amsterdam, 1081 HV, Amsterdam, The Netherlands.
Molecular psychiatry
|February 6, 2024
概括
在Synaptotagmin-1 (Syt1) 中的一种新型突变破坏了神经递质的释放,导致发育延迟和自闭症症状. 这种Syt1突变会损害同步释放,增加自发和异步释放,并导致神经元发生变化.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- синапто塔格明-1 (Syt1) 对于调节神经递质释放至关重要.
- 在Syt1的C2A和C2B域中介于传感和囊泡融合.
- 功能障碍的Syt1与神经发育障碍有关.
研究的目的:
- 研究在发育迟缓和自闭症症状的患者中发现的新Syt1突变 (P401L) 的功能影响.
- 确定这种Syt1突变影响神经传递和神经元形态的细胞机制.
- 阐明改变释放动态在SYT1相关的神经发育障碍中的作用.
主要方法:
- 生成了一个表达正义Syt1突变 (P400L) 的小鼠模型.
- 使用培养Syt1无突变神经元和野生类型神经元进行实验.
- 进行补丁录音以分析神经递质释放动力学 (自发性,异步性,同步性).
- 评估神经元形态,包括树突外长和突触密度.
主要成果:
- Syt1 P400L突变显著增加了自发微型释放 (>500%) 和异步释放 (>100%),同时保持同步释放不受影响.
- 表达Syt1 P400L的神经元表现出减少的树外生长和突触密度.
- 这种突变以主导-负的方式起作用,损害了Syt1与SNARE复合体的相互作用.
- 在Syt1无突变神经元中观察到细胞表型,在野生型神经元中表达过度.
结论:
- Syt1 P401L突变通过破坏自发和异步释放的抑制来破坏神经传递的同步.
- 改变释放动态和神经元结构变化有助于神经发育表型.
- 这项研究强调了Syt1调节释放时间在神经发育和SYT1相关疾病中的关键作用.
相关概念视频
Chemical Synapses
8.8K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
8.8K
Excitatory and Inhibitory Effects of Neurotransmitters
10.0K
When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of...
10.0K
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Fusion of Secretory Vesicles with the Plasma Membrane
11.1K
Proteins and neurotransmitters in secretory vesicles can be released from a cell upon vesicle docking, priming, and fusion with the plasma membrane. Vesicles are docked and primed in preparation for the quick exocytosis of their contents in response to a stimulus. The fusion process is mainly carried out by a SNAP Receptor or SNARE complex, consisting of synaptobrevin, syntaxin-1, and SNAP-25.
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
11.1K
ATP Synthase: Mechanism
14.6K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
14.6K
Mutations
82.3K
Overview
82.3K


